Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma in vitro and in vivo

Esophageal squamous cell carcinoma (ESCC) accounts for almost 90% of esophageal cancer cases and is the sixth most common cause of cancer-associated mortality worldwide. Cisplatin is the standard therapeutic reagent for ESCC; however, chemoresistance frequently occurs after a few weeks, which leads...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiansong, Ji, Huaijun, Zhu, Qiang, Yu, Xinshuang, Du, Juan, Jiang, Zhongmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507449/
https://www.ncbi.nlm.nih.gov/pubmed/31186712
http://dx.doi.org/10.3892/ol.2019.10160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507449/
https://www.ncbi.nlm.nih.gov/pubmed/31186712
http://dx.doi.org/10.3892/ol.2019.10160

Ejemplares similares